Utama › Kolitis Ulseratif › Florida
Kajian klinikal Kolitis Ulseratif di Florida
31 kajian untuk Kolitis Ulseratif sedang mencari peserta di lokasi di Florida.
Bandar di Florida
- Orlando22 kajian
- Miami21 kajian
- Tampa9 kajian
- Sarasota6 kajian
- Kendall5 kajian
- Jacksonville4 kajian
- Coral Springs3 kajian
- St. Petersburg3 kajian
- Spring Hill3 kajian
- Pensacola3 kajian
Teks kajian rasmi (Bahasa Inggeris)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Synergy Healthcare - Bradenton - 17th Avenue West /ID# 284157, Bradenton
- Clinical Research of Osceola /ID# 280593, Kissimmee
- Florida Center For Gastroenterology - Largo /ID# 281059, Largo
- dan 3 lagi
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Access Research Institute, Brooksville
- Gastro Florida, Clearwater
- Digestive and Liver Center of Florida, P.A., Kissimmee
- dan 5 lagi
Mengambil pesertaFasa 4
Umur 18 hingga 80 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06581328A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Nicklaus Children's Hospital - Miami - Southwest 62nd Avenue /ID# 271585, Miami
Mengambil pesertaFasa 3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07071519Confirmatory Clinical Study in Active Ulcerative Colitis
- ARA Professionals, Miami
- Orlando Gastroenterology, P.A., Orlando
- Tropical Clinical Trials, Palmetto Bay
Mengambil pesertaFasa 2
Umur 16 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07296315A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Novum Research, LLC, Clermont
- I.V.A.M. Clinical & Investigational Center, LLC, Doral
- Florida Research Institute, Lakewood Rch
- dan 9 lagi
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Bradenton
- Xencor Investigative Site, Brandon
- Xencor Investigative Site, Jacksonville
- dan 5 lagi
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
Umur 18 hingga 75 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 007, Kissimmee
- 029, Miami
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-026, Orlando
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07845487A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- Nature Coast Clinical Research ( Site 1045), Inverness
- Research Associates of South Florida - Miami - Southwest 8th Street ( Site 1072), Miami
- AdventHealth Orlando ( Site 1074), Orlando
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07463183A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Clinical Research of Osceola, LLC, Kissimmee
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06979336A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- American Institute of Research, Cutler Bay
- Nature Coast Clinical Research, Inverness
- Florida Research Institute, Lakewood Rch
- dan 1 lagi
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07196748Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
- Orlando Health, Orlando
- dan 3 lagi
Mengambil pesertaFasa 3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- NeoClinical Research, Hialeah
- Encore Borland-Groover Clinical Research, Jacksonville
- Clinical Research of Osceola, Kissimmee
- dan 4 lagi
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07186101A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Gastro Health Research - Miami, Miami
- Ezy Medical Research, Miami Lakes
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07483073LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- K2 Medical Research - Daytona Beach, Daytona Beach
- Clinical Research of Osceola, Kissimmee
- Florida Research Institute, Lakewood Rch
- dan 1 lagi
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Endoscopic Research Inc, Orlando
- Alliance Clinical Research of Tampa, LLC, Tampa
Mengambil pesertaFasa 4
Umur 18 hingga 65 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06095128Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
- Miami Clinical Research, Miami
- GCP Clinical Research, Tampa
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07513181A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Royal Palm Clinical Research - Site Number: 8400065, Fort Myers
- Clinical Research of Osceola - Site Number: 8400013, Kissimmee
- Bioresearch Partner-Kendale Lakes - Site Number: 8400053, Miami
- dan 1 lagi
Mengambil pesertaFasa 3
Umur 16 hingga 80 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07185009A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and Patients With Active Ulcerative Colitis
- Syneos Health Miami, Miami
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 55 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07749768A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Florida Research Center Inc., Lakewood Rch
- Sanchez Clinical Research, Inc, Miami
- GCP Clinical Research, Tampa
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07577856A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Primary Care of Osceola, Kissimmee
- Florida Research Institute, Lakewood Rch
- University of Miami, Miami
- dan 1 lagi
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT06636656An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Novum Research, LLC - Site Number: 8400003, Clermont
- Precision Clinical Research-Site Number: 8400059, Coral Springs
- Sarkis Clinical Trials-Ocala - Site Number: 8400048, Gainesville
- dan 12 lagi
Mengambil pesertaFasa 3
Umur 16 hingga 80 · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07184996Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Mayo Clinic Jacksonville, Jacksonville
- Advent Health, Orlando
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT05230173Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- University of Miami, Miami
- AdventHealth, Orlando
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT07237516An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Digestive and Liver Center of Florida Kissimmee, Kissimmee
- Orlando Health/Digestive Health Institute, Orlando
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 64 · Semua jantina · Dikemas kini 9 Jul 2026 · NCT06398626A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- Arnold Palmer Hospital - Center for Digestive Health and Nutrition, Orlando
Mengambil pesertaFasa 2
Umur 12 hingga 17 · Semua jantina · Dikemas kini 8 Jul 2026 · NCT05287126R-3750 in Patients With Mild to Moderate Ulcerative Colitis
- AP Medical Research LLC, Miami
- Edward Jenner Research Group, LLC, Plantation
- Adtremed Research Clinic, Tampa
Mengambil pesertaFasa 1
Umur 18 hingga 65 · Semua jantina · Dikemas kini 12 Jun 2026 · NCT05666960ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
- Med-Care Research Corp, Miami
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 22 ke atas · Semua jantina · Dikemas kini 28 Apr 2026 · NCT06810518Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC)
- University of Miami Health System, Miami
Mengambil peserta
Umur 16 hingga 75 · Semua jantina · Dikemas kini 30 Mac 2026 · NCT06784323A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Miami
- Mirador Therapeutics Selected Site, Miami
- Mirador Therapeutics Selected Site, Miami
- dan 3 lagi
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 12 Mac 2026 · NCT07113522Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- University of Miami Health, Miami
- Orlando Health, Orlando
Mengambil peserta
Umur 18 hingga 85 · Semua jantina · Dikemas kini 8 Jan 2026 · NCT05987852Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.